Journal ArticleCommun Biol · October 16, 2025
Although generally unknown, the age of a newly diagnosed tumor encodes valuable etiologic and prognostic information. Here, we estimate the age of breast cancers, defined as the time from the start of growth to detection, using a measure of epigenetic entr ...
Full textLink to itemCite
Journal ArticleAcad Radiol · July 2024
RATIONALE AND OBJECTIVES: To determine the imaging changes and their associated positive predictive value (PPV) for invasive breast cancer in women undergoing active monitoring for ductal carcinoma in situ (DCIS). MATERIALS AND METHODS: In this seven-year ...
Full textLink to itemCite
ConferenceCancer Research · February 1, 2024
AbstractDuctal carcinoma in situ (DCIS) is a very common non-life threatening, pre-invasive form of breast cancer constituting 25% of all new breast cancer diagnoses in the USA, and is normally treated with ...
Full textCite
ConferenceProgress in Biomedical Optics and Imaging Proceedings of SPIE · January 1, 2024
Digital breast tomosynthesis (DBT), synthetic mammography, and full-field digital mammography (FFDM) are commonly used medical imaging modalities for breast cancer screening. Due to the data complexity, most CAD research applies to only one modality, which ...
Full textCite
Journal ArticleBMJ · October 30, 2023
OBJECTIVE: To examine the association between size and margin status of ductal carcinoma in situ (DCIS) and risk of developing ipsilateral invasive breast cancer and ipsilateral DCIS after treatment, and stage and subtype of ipsilateral invasive breast can ...
Full textLink to itemCite
Journal ArticlebioRxiv · October 2, 2023
Ductal carcinoma in situ (DCIS) and invasive breast cancer share many morphologic, proteomic, and genomic alterations. Yet in contrast to invasive cancer, many DCIS tumors do not progress and may remain indolent over decades. To better understand the heter ...
Full textLink to itemCite
Journal ArticleStat Methods Med Res · June 2023
The true sensitivity of a cancer screening test, defined as the frequency with which the test returns a positive result if the cancer is present, is a key indicator of diagnostic performance. Given the challenges of directly assessing test sensitivity in a ...
Full textLink to itemCite
Journal ArticleRadiology · April 2023
Background Guidelines recommend annual surveillance imaging after diagnosis of ductal carcinoma in situ (DCIS). Guideline adherence has not been characterized in a contemporary cohort. Purpose To identify uptake and determinants of surveillance imaging in ...
Full textLink to itemCite
ConferenceCancer Prevention Research · January 1, 2023
AbstractEarly detection cannot succeed unless there is adequate opportunity for cancer to be diagnosed and intercepted within its early preclinical phase. An understanding of opportunity for early detection ...
Full textCite
ConferenceBreast Cancer Res Treat · April 2022
PURPOSE: Patients diagnosed with ductal carcinoma in situ (DCIS) face trade-offs when deciding among different treatments, including surgery, radiation, and endocrine therapy. A less chosen option is active monitoring. While evidence from clinical trials i ...
Full textLink to itemCite
Journal ArticleAnn Intern Med · April 2022
BACKGROUND: Mammography screening can lead to overdiagnosis-that is, screen-detected breast cancer that would not have caused symptoms or signs in the remaining lifetime. There is no consensus about the frequency of breast cancer overdiagnosis. OBJECTIVE: ...
Full textLink to itemCite
Journal ArticleNat Methods · March 2022
The imminent release of tissue atlases combining multi-channel microscopy with single cell sequencing and other omics data from normal and diseased specimens creates an urgent need for data and metadata standards that guide data deposition, curation and re ...
Full textLink to itemCite
ConferenceCancer Research · February 15, 2022
AbstractBackground: The PRECISION (PREvent ductal Carcinoma In Situ Invasive Overtreatment Now) CRUK Grand Challenge project focusses on discriminating hazardous from indolent ductal carcinoma in situ (DCIS) ...
Full textCite
ConferenceCancer Research · February 15, 2022
AbstractBackground. Breast cancer screening is subject to overdiagnosis, that is the mammographic detection of cancers that would not become symptomatic or otherwise cause harm in the absence of screening. T ...
Full textCite
Journal ArticleRadiology · February 2022
Ductal carcinoma in situ (DCIS) is a nonobligate precursor of invasive cancer, and its detection, diagnosis, and management are controversial. DCIS incidence grew with the expansion of screening mammography programs in the 1980s and 1990s, and DCIS is view ...
Full textLink to itemCite
Journal ArticleBioinformatics · December 22, 2021
MOTIVATION: Conservation is broadly used to identify biologically important (epi)genomic regions. In the case of tumor growth, preferential conservation of DNA methylation can be used to identify areas of particular functional importance to the tumor. Howe ...
Full textLink to itemCite
Journal ArticleBr J Cancer · November 2021
BACKGROUND: Radiotherapy (RT) following breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) reduces ipsilateral breast event rates in clinical trials. This study assessed the impact of DCIS treatment on a 20-year risk of ipsilateral DCIS (i ...
Full textLink to itemCite
ConferenceJournal of Clinical Oncology · May 20, 2021
6516 Background: Due to the elevated risk of ipsilateral invasive breast cancer (iIBC) after diagnosis with primary ductal carcinoma in situ (DCIS), professional guidelines recommend surveillance screening within 6-12 months (mo) ...
Full textCite
Journal ArticleCancer · December 1, 2020
BACKGROUND: Anatomical site is strongly associated with head and neck cancer etiology, and etiology and patient sociodemographic characteristics are prognostic factors for survival. It is not known whether the effects of these predictors persist over the p ...
Full textLink to itemCite
Journal ArticleCancer Epidemiol Biomarkers Prev · December 2020
BACKGROUND: Auto-antibodies to tumor suppressor p53 are found in a subset of patients with colorectal cancer. A recent prospective study in the United States has reported a significant 1.8-fold increased odds for colorectal cancer development with prediagn ...
Full textLink to itemCite
Journal ArticleJ Patient Exp · December 2020
Patient experience is an important dimension of health care quality and is assessed using the standard Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey for inpatients. The HCAHPS scores may vary based on survey response rate ...
Full textLink to itemCite
ConferenceCancer Research · November 1, 2020
AbstractIntroduction. The natural history of preinvasive breast cancer, or ductal carcinoma in situ (DCIS) remains poorly understood. Overcoming this gap would allow risk-appropriate treatment for patients d ...
Full textCite
Journal ArticleMicroorganisms · October 30, 2020
Previously, we found that risk of colorectal cancer (CRC) is increased in individuals with serum antibody response to both Helicobacter pylori (HP) Vacuolating Cytotoxin (VacA) toxin or Streptococcus gallolyticus (SGG) pilus protein Gallo2178. In the prese ...
Full textLink to itemCite
Journal ArticleJ Am Coll Radiol · October 2020
PURPOSE: Lobular neoplasia (LN) detected on breast core needle biopsy is frequently managed with surgical excision because of concern for undersampled malignancy. The authors performed a systematic review and meta-analysis to estimate the risk for upgrade ...
Full textLink to itemCite
Journal ArticleJAMA Surg · August 1, 2020
IMPORTANCE: There are limited data on which factors affect the critical and complex decision to withdraw life-supporting treatment (LST) in patients with severe traumatic brain injury (sTBI). OBJECTIVE: To determine demographic and clinical factors associa ...
Full textOpen AccessLink to itemCite
Journal ArticleBreast Cancer Res · May 27, 2020
BACKGROUND: The incidence of ductal carcinoma in situ (DCIS) has increased substantially since the introduction of mammography screening. Nevertheless, little is known about the natural history of preclinical DCIS in the absence of biopsy or complete excis ...
Full textLink to itemCite
Journal ArticleCell · April 16, 2020
Crucial transitions in cancer-including tumor initiation, local expansion, metastasis, and therapeutic resistance-involve complex interactions between cells within the dynamic tumor ecosystem. Transformative single-cell genomics technologies and spatial mu ...
Full textOpen AccessLink to itemCite
Journal ArticleNat Commun · March 9, 2020
Intra-tumoral heterogeneity (ITH) could represent clonal evolution where subclones with greater fitness confer more malignant phenotypes and invasion constitutes an evolutionary bottleneck. Alternatively, ITH could represent branching evolution with invasi ...
Full textLink to itemCite
Journal ArticlePLoS One · 2020
BACKGROUND: Surgical decision-making in severe traumatic brain injury (TBI) is complex. Neurosurgeons weigh risks and benefits of interventions that have the potential to both maximize the chance of recovery and prolong suffering. Inaccurate prognosticatio ...
Full textLink to itemCite
Journal ArticleJ Natl Cancer Inst · September 1, 2019
BACKGROUND: The vast majority of women diagnosed with ductal carcinoma in situ (DCIS) undergo treatment. Therefore, the risks of invasive progression and competing death in the absence of locoregional therapy are uncertain. METHODS: We performed survival a ...
Full textLink to itemCite
Journal ArticleCancer Epidemiol Biomarkers Prev · August 2019
BACKGROUND: In absence of definitive molecular risk markers, clinical management of patients diagnosed with ductal carcinoma in situ (DCIS) remains largely guided by patient and tumor characteristics. In this study, we analyzed recent trends in DCIS incide ...
Full textLink to itemCite
Journal ArticleRadiology · July 2019
Background Most ductal carcinoma in situ (DCIS) lesions are first detected on screening mammograms as calcifications. However, false-positive biopsy rates for calcifications range from 30% to 87%. Improved methods to differentiate benign from malignant cal ...
Full textLink to itemCite
Journal ArticleStat Methods Med Res · April 2019
Cancer screening can detect cancer that would not have been detected in a patient's lifetime without screening. Standard methods for analyzing screening data do not explicitly account for the possibility that a fraction of tumors may remain latent indefini ...
Full textLink to itemCite
Journal ArticleAm J Epidemiol · January 1, 2019
It is generally accepted that some screen-detected breast cancers are overdiagnosed and would not progress to symptomatic cancer if left untreated. However, precise estimates of the fraction of nonprogressive cancers remain elusive. In recognition of the w ...
Full textLink to itemCite
Journal ArticleSci Rep · November 23, 2018
Genomic intratumoral heterogeneity (ITH) is common in cancers, but the extent of phenotypic ITH is uncertain because most subclonal mutations are passengers. Since tumor phenotypes are largely driven by epigenetics, methylomic analyses can provide insights ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · May 29, 2018
A growing body of evidence suggests that a subset of human cancers grows as single clonal expansions. In such a nearly neutral evolution scenario, it is possible to infer the early ancestral tree of a full-grown tumor. We hypothesized that early tree recon ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · November 2017
PURPOSE: This study was designed to determine invasive cancer upstaging rates at surgical excision following vacuum-assisted biopsy of ductal carcinoma in situ (DCIS) among women meeting eligibility for active surveillance trials. METHODS: Patients with va ...
Full textLink to itemCite
Journal ArticleNat Biotechnol · November 2017
Biological systems can generate microstructured materials that combine organic and inorganic components and possess diverse physical and chemical properties. However, these natural processes in materials fabrication are not readily programmable. Here, we u ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · September 1, 2017
BACKGROUND: The United States has experienced an increase in the incidence of human papillomavirus (HPV)-related cancers that are not screen-detectable. It has been hypothesized, but not directly demonstrated, that this is due to increasing HPV prevalence ...
Full textLink to itemCite
Journal ArticlePapillomavirus Res · June 2017
Health economic modeling has become an invaluable methodology for the design and evaluation of clinical and public health interventions against the human papillomavirus (HPV) and associated diseases. At the same time, relatively little attention has been p ...
Full textLink to itemCite
Journal ArticleJ Theor Biol · April 7, 2017
Bone remodeling is a complex process involving cell-cell interactions, biochemical signaling and mechanical stimuli. Early models of the biological aspects of remodeling were non-spatial and focused on the local dynamics at a fixed location in the bone. Se ...
Full textLink to itemCite
Journal ArticleBull Math Biol · February 2017
In this work we explore the temporal dynamics of spatial heterogeneity during the process of tumorigenesis from healthy tissue. We utilize a spatial stochastic model of mutation accumulation and clonal expansion in a structured tissue to describe this proc ...
Full textLink to itemCite
Journal ArticleCancer Res · December 15, 2016
High rates of local recurrence in tobacco-related head and neck squamous cell carcinoma (HNSCC) are commonly attributed to unresected fields of precancerous tissue. Because they are not easily detectable at the time of surgery without additional biopsies, ...
Full textLink to itemCite
Journal ArticleJ Natl Cancer Inst · May 2016
BACKGROUND: Ductal carcinoma in situ (DCIS) is a noninvasive breast lesion with uncertain risk for invasive progression. Usual care (UC) for DCIS consists of treatment upon diagnosis, thus potentially overtreating patients with low propensity for progressi ...
Full textLink to itemCite
Journal ArticleCell · April 21, 2016
Scale invariance refers to the maintenance of a constant ratio of developing organ size to body size. Although common, its underlying mechanisms remain poorly understood. Here, we examined scaling in engineered Escherichia coli that can form self-organized ...
Full textLink to itemCite
Journal ArticleJ Natl Cancer Inst · December 2015
BACKGROUND: Impact of contemporary treatment of pre-invasive breast cancer (ductal carcinoma in situ [DCIS]) on long-term outcomes remains poorly defined. We aimed to evaluate national treatment trends for DCIS and to determine their impact on disease-spec ...
Full textLink to itemCite
Journal ArticleEpidemics · June 2015
The effectiveness of vaccinating males against the human papillomavirus (HPV) remains a controversial subject. Many existing studies conclude that increasing female coverage is more effective than diverting resources into male vaccination. Recently, severa ...
Full textOpen AccessLink to itemCite
Journal ArticlePLoS Comput Biol · March 2015
Clearance of anogenital and oropharyngeal HPV infections is attributed primarily to a successful adaptive immune response. To date, little attention has been paid to the potential role of stochastic cell dynamics in the time it takes to clear an HPV infect ...
Full textOpen AccessLink to itemCite
Chapter · January 1, 2015
Most cancer types develop the ability to leave their site of origin and spread to distant organs to form metastases, also called secondary cancers. Metastases are the most common cause of death among cancer patients, and hence there is an immense clinical ...
Full textCite
Journal ArticleJ Theor Biol · August 21, 2014
Primary tumors often emerge within genetically altered fields of premalignant cells that appear histologically normal but have a high chance of progression to malignancy. Clinical observations have suggested that these premalignant fields pose high risks f ...
Full textLink to itemCite
Journal ArticleMol Syst Biol · October 8, 2013
Diverse mechanisms have been proposed to explain biological pattern formation. Regardless of their specific molecular interactions, the majority of these mechanisms require morphogen gradients as the spatial cue, which are either predefined or generated as ...
Full textLink to itemCite
Journal ArticleJournal of Computational Physics · March 20, 2012
White noise-driven nonlinear stochastic partial differential equations (SPDEs) of parabolic type are frequently used to model physical systems in space dimensions d= 1, 2, 3. Whereas existence and uniqueness of weak solutions to these equations are well es ...
Full textCite
Journal ArticlePLoS Comput Biol · 2012
Bone is a common site for cancer metastasis. To create space for their growth, cancer cells stimulate bone resorbing osteoclasts. Cytokine RANKL is a key osteoclast activator, while osteoprotegerin (OPG) is a RANKL decoy receptor and an inhibitor of osteoc ...
Full textLink to itemCite
Journal ArticleSIAM Journal on Applied Mathematics · April 27, 2010
The mechanical properties of vertebrate bone are largely determined by a process which involves the complex interplay of three different cell types. This process is called bone remodeling and occurs asynchronously at multiple sites in the mature skeleton. ...
Full textCite
Journal ArticleJ Bone Miner Res · May 2009
During bone remodeling, bone-resorbing osteoclasts and bone-forming osteoblasts are organized in bone multicellular units (BMUs), which travel at a rate of 20-40 mum/d for 6-12 mo, maintaining a cylindrical structure. However, the interplay of local BMU ge ...
Full textLink to itemCite
Journal ArticlePhys Rev E Stat Nonlin Soft Matter Phys · April 2007
The theory relevant to the study of matter in equilibrium with the radiation field is thermal quantum electrodynamics (TQED). We present a formulation of the theory, suitable for nonrelativistic fluids, based on a joint functional integral representation o ...
Full textLink to itemCite